PLIANT THERAPEUTICS, INC. (PLRX)

Latest Insider Confidence Score

2026Q1

40.2
Bearish

Company insider confidence (by quarter)

2020Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Tepper Robert I — 2,362,371 Dec 1, 2022
Third Rock Ventures III, L.P. — 2,362,371 Dec 1, 2022
Third Rock Ventures GP III, L.P. — 2,362,371 Dec 1, 2022
Trv Gp III, Llc — 2,362,371 Dec 1, 2022
Third Rock Ventures IV, L.P. — 2,132,867 Jun 9, 2020

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 22, 2026 Jan 26, 2026 Cummings Keith Lamont CFO Neutral 52.5 - 0.00% ✗ -
Jan 22, 2026 Jan 26, 2026 Kuo Minnie COO Neutral 52.5 - 0.00% ✗ -
Jan 22, 2026 Jan 26, 2026 Cheung Lily Chief Human Resource Officer Neutral 52.5 - 0.00% ✗ -
Jan 22, 2026 Jan 26, 2026 Coulie Bernard CEO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2026 Jan 22, 2026 Cummings Keith Lamont CFO Sell 35.6 -24,002 -7.47% ✓ $30.7K
Jan 20, 2026 Jan 22, 2026 Cheung Lily Chief Human Resource Officer Sell 28.8 -7,534 -14.38% ✓ $9.6K
Jan 20, 2026 Jan 22, 2026 Coulie Bernard CEO Sell 30.0 -89,375 -8.90% ✓ $114.4K
Jan 20, 2026 Jan 22, 2026 Kuo Minnie COO Sell 23.8 -6,917 -15.47% ✓ $8.9K
Dec 22, 2025 Kuo Minnie COO Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Bruhn Suzanne Louise Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 MCCOURT Thomas A Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Curnutte John T Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Krognes Steve E. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Cline Darren S Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 PYOTT DAVID E I Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Huh Hoyoung Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 CROWELL GAYLE A Director Neutral 52.5 - 0.00% ✗ -
Jan 23, 2025 Jan 27, 2025 Cheung Lily Chief Human Resource Officer Neutral 90.0 +25,875 105.40% ✗ -
Jan 23, 2025 Jan 27, 2025 Ouimette Mike General Counsel & Corp. Sec'y Neutral 90.0 +35,000 49.61% ✗ -
Jan 23, 2025 Jan 27, 2025 Hull Hans Chief Business Officer Neutral 90.0 +40,150 16.50% ✗ -
Jan 23, 2025 Jan 27, 2025 Lefebvre Eric Chief Medical Officer Neutral 90.0 +45,650 23.46% ✗ -
Jan 23, 2025 Jan 27, 2025 Cummings Keith Lamont CFO Neutral 90.0 +56,650 21.57% ✗ -
Jan 23, 2025 Jan 27, 2025 Coulie Bernard CEO Neutral 90.0 +162,500 19.35% ✗ -
Jan 17, 2025 Jan 22, 2025 Coulie Bernard CEO Sell 30.0 -52,419 -5.87% ✓ $587.2K
Jan 17, 2025 Jan 22, 2025 Cummings Keith Lamont CFO Sell 32.5 -20,148 -7.13% ✓ $225.7K
Jan 17, 2025 Jan 22, 2025 Hull Hans Chief Business Officer Sell 32.5 -15,936 -6.15% ✓ $178.5K
Jan 17, 2025 Jan 22, 2025 Lefebvre Eric Chief Medical Officer Sell 28.8 -18,478 -8.67% ✓ $207K
Jan 17, 2025 Jan 22, 2025 Cheung Lily Chief Human Resource Officer Sell 28.8 -3,740 -13.22% ✓ $41.9K
Jan 17, 2025 Jan 22, 2025 Ouimette Mike General Counsel & Corp. Sec'y Sell 12.5 -23,500 -24.99% ✓ $261.1K
Jul 10, 2024 Jul 12, 2024 Lefebvre Eric Chief Medical Officer Sell 32.5 -12,319 -5.47% ✓ $142.4K
Jul 10, 2024 Jul 12, 2024 Hull Hans Chief Business Officer Sell 37.5 -9,900 -3.68% ✓ $114.4K
Jul 10, 2024 Jul 12, 2024 Cummings Keith Lamont CFO Sell 37.5 -10,911 -3.72% ✓ $126.1K
Jul 10, 2024 Jul 12, 2024 Coulie Bernard CEO Sell 35.0 -38,710 -4.16% ✓ $447.5K
Jul 10, 2024 Jul 12, 2024 Ouimette Mike General Counsel & Corp. Sec'y Sell 28.8 -7,656 -7.53% ✓ $88.5K
Jul 9, 2024 Jul 11, 2024 Lefebvre Eric Chief Medical Officer Neutral 90.0 +24,063 11.95% ✗ -
Jul 9, 2024 Jul 11, 2024 Hull Hans Chief Business Officer Neutral 85.0 +19,337 7.74% ✗ -
Jul 9, 2024 Jul 11, 2024 Cummings Keith Lamont CFO Neutral 85.0 +21,313 7.84% ✗ -
Jul 9, 2024 Jul 11, 2024 Coulie Bernard CEO Neutral 85.0 +75,625 8.84% ✗ -
Jul 9, 2024 Jul 11, 2024 Ouimette Mike General Counsel & Corp. Sec'y Neutral 90.0 +14,954 17.24% ✗ -
Jun 13, 2024 Jun 17, 2024 MCCOURT Thomas A Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 Huh Hoyoung Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 PYOTT DAVID E I Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 Shah Smital Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 Cline Darren S Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 CROWELL GAYLE A Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 Bruhn Suzanne Louise Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 Curnutte John T Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 Krognes Steve E. Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2024 Krognes Steve E. Director Neutral 52.5 - 0.00% ✗ -
May 2, 2024 May 6, 2024 Cummings Keith Lamont CFO Neutral 52.5 - 0.00% ✗ -
Jan 23, 2024 Jan 24, 2024 Lefebvre Eric Chief Medical Officer Neutral 90.0 +42,900 27.34% ✗ -
Jan 23, 2024 Jan 24, 2024 Hull Hans Chief Business Officer Neutral 90.0 +31,500 14.53% ✗ -
Jan 23, 2024 Jan 24, 2024 Ouimette Mike General Counsel & Corp. Sec'y Neutral 90.0 +31,500 57.02% ✗ -
Jan 23, 2024 Jan 24, 2024 Cummings Keith Lamont CFO Neutral 90.0 +55,250 28.39% ✗ -
Jan 23, 2024 Jan 24, 2024 Cheung Lily Chief Human Resource Officer Neutral 90.0 +26,000 3270.44% ✗ -
Jan 23, 2024 Jan 24, 2024 Coulie Bernard CEO Neutral 90.0 +128,150 17.66% ✗ -
Jan 17, 2024 Jan 19, 2024 Cummings Keith Lamont CFO Sell 37.5 -9,781 -4.79% ✓ $168.5K
Jan 17, 2024 Jan 19, 2024 Hull Hans Chief Business Officer Sell 37.5 -9,786 -4.32% ✓ $168.6K
Jan 17, 2024 Jan 19, 2024 Coulie Bernard CEO Sell 35.0 -25,721 -3.42% ✓ $443.2K
Jan 17, 2024 Jan 19, 2024 Lefebvre Eric Chief Medical Officer Sell 32.5 -10,295 -6.16% ✓ $177.4K
Jan 17, 2024 Jan 19, 2024 Ouimette Mike General Counsel & Corp. Sec'y Sell 28.8 -5,197 -8.60% ✓ $89.5K
Aug 3, 2023 Aug 7, 2023 Hull Hans Chief Business Officer Sell 35.0 -31,319 -4.67% ✓ $626.6K
Jul 20, 2023 Jul 21, 2023 Ouimette Mike General Counsel & Corp. Sec'y Sell 32.5 -4,755 -7.29% ✓ $83.5K
Jul 17, 2023 Jul 19, 2023 Ouimette Mike General Counsel & Corp. Sec'y Sell 20.0 -12,778 -16.39% ✓ $230.1K
Jul 17, 2023 Jul 19, 2023 Lefebvre Eric Chief Medical Officer Sell 22.5 -22,321 -11.78% ✓ $402K
Jul 17, 2023 Jul 19, 2023 Hull Hans Chief Business Officer Sell 30.0 -17,937 -6.67% ✓ $323K
Jul 17, 2023 Jul 19, 2023 Cummings Keith Lamont CFO Sell 26.3 -19,771 -8.84% ✓ $356.1K
Jul 17, 2023 Jul 19, 2023 Coulie Bernard CEO Sell 23.8 -70,150 -8.54% ✓ $1.3M
Jul 14, 2023 Jul 18, 2023 Ouimette Mike General Counsel & Corp. Sec'y Neutral 90.0 +27,187 53.53% ✗ -
Jul 14, 2023 Jul 18, 2023 Lefebvre Eric Chief Medical Officer Neutral 90.0 +43,750 30.01% ✗ -
Jul 14, 2023 Jul 18, 2023 Hull Hans Chief Business Officer Neutral 90.0 +35,156 15.04% ✗ -
Jul 14, 2023 Jul 18, 2023 Cummings Keith Lamont CFO Neutral 90.0 +38,750 20.94% ✗ -
Jul 14, 2023 Jul 18, 2023 Coulie Bernard CEO Neutral 90.0 +137,500 20.10% ✗ -
Jun 13, 2023 Jun 14, 2023 Cummings Keith Lamont CFO Neutral 52.5 - 0.00% ✗ -
Jun 9, 2023 Jun 12, 2023 Cummings Keith Lamont CFO Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Shah Smital Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 PYOTT DAVID E I Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 MCCOURT Thomas A Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Huh Hoyoung Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Curnutte John T Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 CROWELL GAYLE A Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Cline Darren S Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 8, 2023 Bruhn Suzanne Louise Director Neutral 52.5 - 0.00% ✗ -
Mar 30, 2023 Apr 3, 2023 Ouimette Mike General Counsel & Corp. Sec'y Sell 25.0 -7,751 -13.24% ✓ $206.3K
Mar 30, 2023 Apr 3, 2023 Lefebvre Eric Chief Medical Officer Sell 30.0 -11,245 -7.16% ✓ $298.2K
Mar 30, 2023 Apr 3, 2023 Hull Hans Chief Business Officer Sell 37.5 -9,036 -3.72% ✓ $239.6K
Mar 30, 2023 Apr 3, 2023 Cummings Keith Lamont CFO Sell 30.0 -9,960 -6.29% ✓ $264.1K
Mar 30, 2023 Apr 3, 2023 Coulie Bernard CEO Sell 35.0 -35,339 -4.91% ✓ $937.2K
Mar 29, 2023 Mar 31, 2023 Ouimette Mike General Counsel & Corp. Sec'y Neutral 90.0 +13,593 30.24% ✗ -
Mar 29, 2023 Mar 31, 2023 Lefebvre Eric Chief Medical Officer Neutral 90.0 +21,874 16.18% ✗ -
Mar 29, 2023 Mar 31, 2023 Hull Hans Chief Business Officer Neutral 85.0 +17,578 7.81% ✗ -
Mar 29, 2023 Mar 31, 2023 Cummings Keith Lamont CFO Neutral 90.0 +19,375 13.93% ✗ -
Mar 29, 2023 Mar 31, 2023 Coulie Bernard CEO Neutral 90.0 +68,749 10.57% ✗ -
Mar 6, 2023 Mar 8, 2023 MCCOURT Thomas A Director Neutral 52.5 - 0.00% ✗ -
Mar 8, 2023 MCCOURT Thomas A Director Neutral 52.5 - 0.00% ✗ -
Mar 6, 2023 Mar 8, 2023 Cline Darren S Director Neutral 52.5 - 0.00% ✗ -
Mar 8, 2023 Cline Darren S Director Neutral 52.5 - 0.00% ✗ -